Henry Schein, Inc.
HSIC
Clasificación en acciones
#2167
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive... Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Precio por acción
$84.67
Última sincronización: 2026-10-20
Capitalización bursátil
$9.44B
Cambio (1 día)
0.84%
Cambio (1 año)
31.83%
País
US
Comercio Henry Schein, Inc. (HSIC)
Categoría
Healthcare
Ratio P/E de Henry Schein, Inc. (HSIC)
Ratio P/E al October 2026 TTM: 24.73
Según los últimos informes financieros y el precio de las acciones de Henry Schein, Inc., el P/E actual (TTM) de la empresa es 24.73. Al final de 2023, la empresa tenía un P/E de 23.77.
Historial del ratio P/E de Henry Schein, Inc. desde 2000 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2026 (TTM) | 24.73 | 8.03% |
| 2024 | 22.89 | -3.70% |
| 2023 | 23.77 | 17.68% |
| 2022 | 20.20 | 21.43% |
| 2021 | 16.64 | -28.39% |
| 2020 | 23.23 | 69.76% |
| 2019 | 13.69 | -21.39% |
| 2018 | 17.41 | -19.52% |
| 2017 | 21.63 | 14.87% |
| 2016 | 18.83 | -11.62% |
| 2015 | 21.31 | 9.37% |
| 2014 | 19.48 | 9.02% |
| 2013 | 17.87 | 26.38% |
| 2012 | 14.14 | 14.16% |
| 2011 | 12.39 | -8.13% |
| 2010 | 13.48 | 13.54% |
| 2009 | 11.88 | 16.81% |
| 2008 | 10.17 | -49.24% |
| 2007 | 20.03 | -2.92% |
| 2006 | 20.63 | 4.84% |
| 2005 | 19.68 | 8.99% |
| 2004 | 18.06 | 7.06% |
| 2003 | 16.86 | 29.44% |
| 2002 | 13.03 | -54.17% |
| 2001 | 28.43 | -28.91% |
| 2000 | 39.99 | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| 26.02 | 5.23% |
US
|
|
| - | - |
US
|
|
| 34.08 | 37.81% |
US
|
|
| - | - |
US
|
|
| 45.62 | 84.47% |
AU
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.